Bristol-Myers: FDA wants factory's problems fixed

NEW YORK (AP) - October 26, 2010

The Food and Drug Administration, in a warning letter, told the drugmaker it could hold up approval of new products if the deficiencies are not corrected quickly.

Bristol Chief Executive Lamberto Andreotti disclosed the investigation during a conference call with analysts about Bristol's third-quarter results.

He said Bristol-Myers has told FDA what corrections it is making. He says the company must resolve the problems before FDA will approve sales of a new biologic drug to prevent rejection of transplanted organs.

Copyright © 2021 WPVI-TV. All Rights Reserved.